UPGUYS Founders Mat Rezaei and Ramin Behzadi Named 2026 EY Entrepreneur Of The Year® Pacific Region Finalists as Canada's Leading TRT Platform Scales Nationwide
The recognition adds to UPGUYS's #8 ranking on The Globe and Mail's 2025 Canada's Top Growing Companies list -- back-to-back years of tier-one recognition for the Burnaby-based men's health platform.
BURNABY, BC, June 9, 2026 /CNW/ - Mat Rezaei and Ramin Behzadi, co-founders of UPGUYS -- Canada's leading platform for testosterone replacement therapy (TRT) and hormone optimization -- have been named 2026 EY Entrepreneur Of The Year® Pacific Region finalists. The recognition places the Burnaby, B.C. founders among a Pacific cohort that includes leaders from Xenon Pharmaceuticals, Merchant Growth, and Beautifi, and follows UPGUYS's #8 ranking on The Globe and Mail's 2025 Canada's Top Growing Companies list, where the company posted three-year revenue growth of 3,052%.
EY Entrepreneur Of The Year® is one of the most established business recognition programs in the world, identifying entrepreneurs across Canada through an independent panel of judges. Regional finalists were announced this month. Regional winners were announced in October 2026; the national winner will be named in November 2026. Rezaei and Behzadi are both individually listed among the Pacific region's 2026 finalists.
UPGUYS has served more than 170,000 Canadian patients nationwide since 2019 across its men's health services, with testosterone replacement therapy (TRT) and hormone optimization as its flagship category. Care is delivered through a network of Canadian-licensed practitioners and two licensed Canadian pharmacies, in Burnaby, BC and Toronto, ON. The company's testosterone and hormone optimization programs are available at upguys.com/testosterone.
The recognition lands amid growing national attention on men's health access. Despite testosterone replacement therapy and hormone optimization being among the most-searched men's health topics in Canada, many men still go without assessment because conventional pathways are slow or hard to navigate. UPGUYS was built to close that gap with a trusted, practitioner-led model that connects patients to Canadian-licensed clinicians and dispenses through its own licensed pharmacies.
"Being named an EY Entrepreneur Of The Year® Pacific Region finalist alongside this group of Canadian builders is an honour we share with our entire team," said Mat Rezaei, co-founder and Chief Executive Officer of UPGUYS. "We started UPGUYS because too many Canadian men were going without basic hormone and men's health care simply because the front door was too hard to find. Our focus has been building a trusted, practitioner-led platform that meets patients where they are."
"This recognition reflects the trust Canadians have placed in us," said Ramin Behzadi, co-founder and Chief Scientific Officer of UPGUYS. "More than 170,000 Canadian patients have come to us for care, and testosterone replacement therapy and hormone optimization are at the heart of what we do. Our responsibility is to keep that care evidence-based, accessible, and grounded in Canadian-licensed clinical oversight from coast to coast."
Clinical leadership at UPGUYS is physician-led under Medical Director Dr. Dimitre Ranev, with day-to-day care delivered by a nationwide network of Canadian-licensed practitioners. UPGUYS is LegitScript-certified.
About UPGUYS Health
UPGUYS is a Canadian men's longevity and hormone optimization platform with pharmacy services. Founded in 2019 and headquartered in Burnaby, British Columbia, UPGUYS serves patients in 12 Canadian provinces and territories through a network of Canadian-licensed practitioners and two licensed Canadian pharmacies, in Burnaby, BC and Toronto, ON. UPGUYS has served more than 200,000 Canadian patients. UPGUYS provides low testosterone treatment, available in Alberta, British Columbia, Manitoba, Ontario, Quebec and Saskatchewan, and related men's health care. Low testosterone treatment, sometimes called testosterone replacement therapy (TRT), begins with a symptom review and morning blood tests; a licensed practitioner determines whether treatment is appropriate for each patient. UPGUYS was ranked No. 4 on The Globe and Mail's 2026 Canada's Top Growing Companies list, with three-year revenue growth of 5,308%, its second consecutive year in the top 10. Its pharmacies are licensed by the College of Pharmacists of British Columbia (licence 38287) and accredited by the Ontario College of Pharmacists (accreditation 309322), and the company is LegitScript-certified. Learn more at upguys.com.
UPGUYS is part of UPGUYS Health Inc., whose brand portfolio includes UPGUYS (men's health), Everbliss (women's health), UPRX (licensed pharmacies), Upclinic (telehealth), and Uphealth Pharma (pharmaceutical contract manufacturing).
Edited on November 9, 2026: the EY Entrepreneur Of The Year® timeline was corrected (regional winners were announced in October 2026; the national winner will be named in November 2026), a regulatory compliance statement was removed from the paragraph on clinical leadership, the About UPGUYS Health section was updated to current company information, and the wire's media contact and source lines are not reproduced. The original release is available via Cision/CNW.
